1a8j:L     (PCA1) to   (VAL109)  IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME  |   ASPARTAME, LIGAND BINDING, IMMUNOTHERAPEUTIC AGENT, SURROGATE RECEPTOR, MCG(HUMAN) BENCE-JONES DIMER, IMMUNOGLOBULIN 
1ai1:L     (VAL3) to   (ALA109)  HIV-1 V3 LOOP MIMIC  |   COMPLEX (ANTIBODY/PEPTIDE), ANTIBODY, CONSTRAINED HIV-1 V3 LOOP PEPTIDE, IMMUNOGLOBULIN 
1nmb:L     (ILE2) to   (ILE106)  THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY  |   COMPLEX (HYDROLASE-IMMUNOGLOBULIN), COMPLEX (HYDROLASE- IMMUNOGLOBULIN) COMPLEX 
1nmc:L     (ASP1) to   (ILE106)  COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE  |   COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX (SINGLE- CHAIN ANTIBODY-ANTIGEN) COMPLEX 
1nmc:C     (ASP1) to   (ILE106)  COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE  |   COMPLEX (SINGLE-CHAIN ANTIBODY-ANTIGEN), HYDROLASE, COMPLEX (SINGLE- CHAIN ANTIBODY-ANTIGEN) COMPLEX 
1axt:L     (LEU2) to   (ILE106)  IMMUNE VERSUS NATURAL SELECTION: ANTIBODY ALDOLASES WITH THE RATES OF NATURAL ENZYMES  |   IMMUNOGLOBULIN, ANTIBODY FAB', CATALYST, ALDOLASE REACTION 
3esu:F     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF ANTHRAX-NEUTRALIZING SINGLE-CHAIN ANTIBODY 14B7  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3et9:F     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY 1H  |   SINGLE-CHAIN FV, MONOCLONAL ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1baf:L     (VAL3) to   (LEU106)  2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3s34:L     (ASP1) to   (ILE106)  STRUCTURE OF THE 1121B FAB FRAGMENT  |   VEGF RECEPTOR DOMAIN 3, IMMUNE SYSTEM 
4hjg:A     (ASP1) to   (ILE106)  MEDITOPE-ENABLED TRASTUZUMAB  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC 
2pcp:A     (VAL2) to   (ILE106)  ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE  |   IMMUNOGLOBULIN 
4x4x:B     (ILE2) to   (ILE106)  RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT.  |   ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM 
3f58:L     (ASP1) to   (LEU106)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, IMMUNE SYSTEM 
1oar:M     (VAL3) to   (LEU109)  FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED  |   IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY 
1oar:O     (VAL3) to   (LEU109)  FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED  |   IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE, CONFORMATIONAL DIVERSITY, MULTISPECIFICITY 
1oax:O     (ALA2) to   (LEU109)  FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE  |   IMMUNE SYSTEM, ANTIBODY-COMPLEX, ANTIBODY, ALLERGY, IGE 
1bz7:A     (MET4) to   (ILE106)  FAB FRAGMENT FROM MURINE ASCITES  |   ANTIBODY (FAB FRAGMENT), IMMUNE SYSTEM 
4hxb:L     (LEU3) to   (ILE106)  CRYSTAL STRUCTURE OF 6B9 FAB  |   ANTIBODY, FAB, COMPLEMENTARITY DETERMINING REGIONS, CARBOHYDRATE- BINDING, IMMUNE SYSTEM 
4hzl:B     (ASP1) to   (ALA114)  NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN  |   IG DOMAIN, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
1cfs:A     (LYS3) to   (LEU106)  ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH AN EPITOPE-UNRELATED PEPTIDE  |   POLYSPECIFICITY, CROSS REACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1 
3fzu:L     (ILE2) to   (ILE106)  IGG1 FAB CHARACTERIZED BY H/D EXCHANGE  |   IGG1 FAB, IMMUNE SYSTEM 
3fzu:D     (ILE2) to   (ILE106)  IGG1 FAB CHARACTERIZED BY H/D EXCHANGE  |   IGG1 FAB, IMMUNE SYSTEM 
4xnq:A     (TYR1) to   (VAL104)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xnq:L     (TYR1) to   (THR103)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xnz:C     (GLU1) to   (ILE101)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC06B IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
1p4i:L     (ALA2) to   (LEU148)  CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4  |   PEPTIDE BINDER, SCFV, PICOMOLAR BINDER, IMMUNE SYSTEM 
4xrc:A     (TYR1) to   (VAL104)  ANTIBODY HEMAGGLUTININ COMPLEXES  |   ANTIBODY, HEMAGGLUTININ, NEUTRALIZATION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4xxd:A     (VAL2) to   (ILE106)  CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB  |   FAB, AMYLOID-BETA, IMMUNE SYSTEM 
1dvf:C     (ILE2) to   (ILE106)  IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX  |   COMPLEX (IDIOTOPE-ANTIIDIOTOPE), IMMUNOGLOBULIN 
1e4x:L     (ILE2) to   (ILE106)  CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT  |   IMMUNE SYSTEM, COMPLEX (ANTIBODY/ANTIGEN), CROSS-REACTIVITY, PROTEIN-PEPTIDE RECOGNITION 
2dd8:L     (TYR3) to   (VAL106)  CRYSTAL STRUCTURE OF SARS-COV SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH NEUTRALIZING ANTIBODY  |   SARS, S PROTEIN, ANTIBODY, EPITOPES, VACCINES, INHIBITORS, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jhw:L     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25  |   IMMUNOGLOBULIN; TYPE I FUSION PROTEIN, MEMBRANE FUSION, IMMUNE SYSTEM 
3h3p:L     (GLU1) to   (VAL107)  CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX  |   EPITOPE-SCAFFOLD FV COMPLEX, IMMUNE SYSTEM 
1fai:L     (ASP1) to   (ILE106)  THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY  |   IMMUNOGLOBULIN 
2eiz:A     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX  |   ANTIBODY, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX 
4k2u:M     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT  |   DBL DOMAIN, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, CELL ATTACHMENT, IMMUNITY, RECEPTOR, LIGAND, EXTRACELLULAR, IMMUNE SYSTEM 
1frg:L     (ILE2) to   (LEU112)  CRYSTAL STRUCTURE, SEQUENCE, AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY  |   IMMUNOGLOBULIN/VIRUS HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2f19:L     (ASP1) to   (ILE106)  THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9, FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY  |   IMMUNOGLOBULIN 
2vc2:L     (ILE2) to   (ILE106)  RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, 
2vdk:L     (ILE2) to   (ILE106)  RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, PHOSPHORYLATION, 
2vdo:L     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
2fl5:E     (SER1) to   (VAL106)  COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY  |   HUMAN ANTIBODY, RIBOFLAVIN-BINDING, COFACTOR, MULTIPLE MYELOMA, IGGGAR, IMMUNE SYSTEM 
3hr5:A     (ILE2) to   (ILE111)  M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB  |   FAB-PEPTIDE COMPLEX, IMMUNE SYSTEM 
1s3k:L     (ASP1) to   (ILE111)  CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE  |   IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
4kph:M     (VAL3) to   (ILE106)  STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN  |   ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM, CARBOHYDRATE/SUGAR BINDING, PLASMA 
2vxs:O     (PHE2) to   (VAL106)  STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY  |   EPITOPE, COMPLEX, ANTIBODY, SECRETED, CYTOKINE, GLYCOPROTEIN, INTERLEUKIN-17 
2gfb:G     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:I     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
2gfb:K     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC FAB HAVING ESTERASE-LIKE ACTIVITY  |   IMMUNOGLOBULIN 
3idx:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222  |   HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM 
3idy:L     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221  |   HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM 
3idy:C     (GLN3) to   (ILE106)  CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C2221  |   HIV-1, ANTIBODY, GP120, B13, ENVELOPE GLYCAN PROTEIN, CD4-BINDING SITE, AIDS, APOPTOSIS, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, HOST- VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRAL IMMUNOEVASION, VIRION, IMMUNE SYSTEM 
2w0k:B     (MET3) to   (VAL110)  CRYSTAL STRUCTURE OF THE RECOMBINANT VARIABLE DOMAIN 6JAL2  |   FIBRILS, GERM LINE, ANTIBODIES, FIBRINOGENIC, IMMUNE SYSTEM 
3iet:C     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
2hff:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF CB2 FAB  |   FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM 
2hfg:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB  |   FAB FRAGMENT, TNFRSF, ANTIBODY-RECEPTOR COMPLEX, CRD, IMMUNE SYSTEM 
3iy1:A     (LEU1) to   (LEU104)  VARIABLE DOMAINS OF THE WAM OF FAB B FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB B COMPLEX  |   CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM 
1ind:L     (ALA2) to   (LEU109)  HOW THE ANTI-(METAL CHELATE) ANTIBODY CHA255 IS SPECIFIC FOR THE METAL ION OF ITS ANTIGEN: X-RAY STRUCTURES FOR TWO FAB'(SLASH)HAPTEN COMPLEXES WITH DIFFERENT METALS IN THE CHELATE  |   IMMUNOGLOBULIN 
1iqw:L     (VAL3) to   (ALA113)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A  |   IMMUNOGLOBULIN, FAB, ANTI_FAS, AGONISTIC ANTIBODY, APOPTOSIS, IMMUNE SYSTEM 
1j05:A     (VAL3) to   (ILE106)  THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2x7l:B     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2x7l:D     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2x7l:F     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2x7l:I     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2x7l:K     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2x7l:L     (LEU2) to   (THR112)  IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT  |   NUCLEAR EXPORT, IMMUNE SYSTEM, POST-TRANSCRIPTIONAL REGULATION 
2xkn:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7  |   IMMUNE SYSTEM, IMMUNOGLOBULIN 
4n1c:B     (ILE2) to   (ILE106)  STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION  |   IMMUNOGLOBULIN VARIABLE DOMAIN HOMODIMER, PROTEIN-PROTEIN COMPLEX, IG DOMAIN, IMMUNE SYSTEM-HYDROLASE COMPLEX 
5b3j:L     (ILE2) to   (ALA108)  ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL  |   NMDA RECEPTOR, TRANSPORT PROTEIN 
4odv:L     (ILE2) to   (ILE106)  FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
1xiw:C     (ILE3) to   (ILE107)  CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT  |   CD3-EPSILON, CD3-DELTA, UCHT1-SCFV, IMMUNOGLOBULIN FOLD, ANTIBODY-ANTIGEN COMPLEX, MEMBRANE PROTEIN/IMMUNE SYSTEM COMPLEX 
1xiw:G     (ILE3) to   (ILE107)  CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT  |   CD3-EPSILON, CD3-DELTA, UCHT1-SCFV, IMMUNOGLOBULIN FOLD, ANTIBODY-ANTIGEN COMPLEX, MEMBRANE PROTEIN/IMMUNE SYSTEM COMPLEX 
1mam:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN  |   IMMUNOGLOBULIN 
1mcr:A     (PRO1) to   (GLY111)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mlc:C     (ILE2) to   (ILE106)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME  |   COMPLEX (ANTIBODY/ANTIGEN) 
1moe:B     (ASP1) to   (ILE110)  THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.  |   ANTI CARCINOEMBRYONIC ANTIGEN, T84.66, DIABODY, DIMER, SCFV, VARIABLE DOMAIN, IMMUNE SYSTEM 
3kym:C     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
3l5x:L     (GLU1) to   (ILE106)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB  |   IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
1yy9:C     (ILE2) to   (LEU106)  STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC- C225  |   CELL SURFACE RECEPTOR; TYROSINE KINASE; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4poz:C     (ASP1) to   (ILE106)  FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9  |   ANTIBODY, ALLERGY, IMMUNE SYSTEM 
5do2:L     (ASP1) to   (ILE106)  COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY  |   RECEPTOR-BINDING DOMAIN OF MERS-COV SPIKE, 4C2 ANTIBODY, NEURALIZATION, RECEPTOR-BINDING BLOCKING., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4pp2:A     (ASP1) to   (ALA109)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4pp2:C     (ASP1) to   (ALA109)  THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9  |   ALLERGEN, ANTIBODY, IMMUNE SYSTEM 
4amk:L     (ALA2) to   (LEU109)  FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10  |   IMMUNE SYSTEM, 13G10, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
5dqj:L     (ASP1) to   (ILE106)  STRUCTURE OF UNLIGANDED S55-5 FAB  |   ANTIBODY, FAB, CARBOHYDRATE BINDING, PHOSPHOLIPID, IMMUNE SYSTEM 
5dqj:B     (VAL3) to   (ILE106)  STRUCTURE OF UNLIGANDED S55-5 FAB  |   ANTIBODY, FAB, CARBOHYDRATE BINDING, PHOSPHOLIPID, IMMUNE SYSTEM 
3lhp:L     (GLU1) to   (LYS108)  CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX  |   EPITOPE-SCAFFOLD, IMMUNE SYSTEM 
4at6:B     (ALA2) to   (LEU109)  FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7  |   IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
5dyo:B     (VAL3) to   (ALA114)  FAB43.1 COMPLEX WITH FLOURESCEIN  |   ANTIBODY FAB FLOURESCEIN, IMMUNE SYSTEM 
5e94:A     (ASP1) to   (ILE106)  ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN  |   ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN 
5e94:C     (ASP1) to   (ILE106)  ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN  |   ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN 
2a6d:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE  |   GERMLINE, FAB, ANTIBODY, IMMUNE SYSTEM 
2a6j:A     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65  |   GERMLINE, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3b2v:L     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8  |   CELL SURFACE RECEPTOR; GLYCOPROTEIN; ANTIGEN:ANTIBODY COMPLEX; FAB FRAGMENT; ANTITUMOR; DRUG, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEASE MUTATION, KINASE, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SECRETED, TRANSFERASE, TRANSMEMBRANE, TYROSINE- PROTEIN KINASE, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4qhu:L     (VAL3) to   (VAL107)  CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX  |   ANTIBODY-ANTIGEN INTERACTION, RECEPTOR DIFFERENTIATION, MOLECULAR ASYMMETRY, CYSTINE KNOT, CYTOKINE IL-17, IL-17RA, IL-17RC, IMMUNE SYSTEM 
4qhu:A     (VAL3) to   (VAL107)  CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX  |   ANTIBODY-ANTIGEN INTERACTION, RECEPTOR DIFFERENTIATION, MOLECULAR ASYMMETRY, CYSTINE KNOT, CYTOKINE IL-17, IL-17RA, IL-17RC, IMMUNE SYSTEM 
3b5g:A     (ASN1) to   (VAL110)  CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, LIGHT CHAIN VARIABLE DOMAIN, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
3b9k:C     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3mj8:A     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS  |   ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM 
3mnv:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT  |   HIV-1, HIV, GP41, MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
3bn9:E     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2  |   ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE 
3cdy:B     (ILE2) to   (ILE106)  AL-09 H87Y, IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN  |   GREEK KEY BETA BARREL, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, AMYLOIDOSIS, IMMUNE SYSTEM 
3nh7:M     (ILE2) to   (VAL107)  CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA  |   ANTIBODY-ANTIGEN COMPLEX, BMP RECEPTOR EXTRACELLULAR DOMAIN, BONE MORPHOGENETIC PROTEIN, IMMUNE SYSTEM 
3cmo:X     (ILE2) to   (ILE106)  HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18  |   HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4rzc:D     (VAL3) to   (SER107)  FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE  |   ANTIBODY VARIABLE FRAGMENT, MANNOSE-6-PHOSPHATE, IMMUNE SYSTEM 
4rzc:F     (LEU2) to   (SER107)  FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE  |   ANTIBODY VARIABLE FRAGMENT, MANNOSE-6-PHOSPHATE, IMMUNE SYSTEM 
5hi4:D     (ASN1) to   (VAL106)  BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS  |   IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX 
5hi4:L     (ASN1) to   (VAL106)  BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS  |   IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX 
5hi5:D     (ASN1) to   (VAL106)  BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS  |   IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX 
5hi5:L     (ASN1) to   (VAL106)  BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS  |   IL-17A, PSORIASIS, MD SIMULATION, SULFONYL FLUORIDE, INHIBITOR, MACROCYCLE, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4dke:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
4ub0:L     (ILE2) to   (ILE106)  NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE  |   FAB, KNOBS-INTO-HOLES, BISPECIFIC, IMMUNE SYSTEM 
5i30:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION  |   ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM 
4uik:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1  |   IMMUNE SYSTEM, QUININE-DEPENDENT, MOUSE MAB 
5if0:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF VRC01C-HUGL2 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD-GT8 AT 2.44 A  |   HIV-1 GP120, ENGINEERED OUTER DOMAIN (EOD), GERMLINE TARGETING, CD4 BINDING SITE, VRC01-CLASS NAIVE HUMAN GERMLINE ANTIBODY, IMMUNE SYSTEM, VIRAL-PROTEIN COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4edw:L     (GLN3) to   (ILE106)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
4edx:L     (ASP1) to   (ILE106)  NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911  |   CYSTINE KNOT, IMMUNOGLOBULIN, GROWTH/SURVIVAL FACTOR, IMMUNE SYSTEM 
5ir1:C     (ILE2) to   (LEU106)  CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
3qpx:L     (GLN3) to   (THR108)  CRYSTAL STRUCTURE OF FAB C2507  |   IMMUNOGLOBULIN, IMMUNE SYSTEM, MOUSE IL-17A 
3qum:A     (VAL3) to   (ALA109)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY  |   KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
3ra7:M     (ASP1) to   (ILE106)  BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY  |   FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM 
4fze:L     (SER2) to   (VAL106)  CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.  |   ADCC, ANTI-HIV-1 ENV ANTIBODY N26_I1, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM, CD4I ANTIBODY, FAB 
8fab:A     (GLU3) to   (VAL105)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE HUMAN MYELOMA IMMUNOGLOBULIN IGG HIL AT 1.8 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
4hdi:A     (VAL3) to   (ALA114)  CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS  |   IGG, FAB, IMMUNE SYSTEM 
4hg4:S     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hg4:W     (ASP1) to   (GLU105)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3eyv:L     (GLN3) to   (ILE111)  ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS  |   IMMUNOGLOBULIN FOLD, BETA BARREL, HUMANIZED ANTIBODY, ANTIGEN BINDING FRAGMENT, IMMUNE SYSTEM 
1bre:C     (ASP1) to   (ILE106)  IMMUNOGLOBULIN LIGHT CHAIN PROTEIN  |   IMMUNOGLOBULIN 
1c5d:L     (ILE2) to   (ALA108)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3u9p:L     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT  |   BETA BARREL, TRANSPORT PROTEIN, IMMUNE SYSTEM 
2eks:A     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX  |   IMMUNE SYSTEM, HYDROLASE, IMMUNE SYSTEM/HYDROLASE COMPLEX 
1fve:C     (ILE2) to   (ILE106)  X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING  |   IMMUNOGLOBULIN 
2f58:L     (ASP1) to   (LEU106)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, IMMUNE SYSTEM 
4zpt:B     (ASP1) to   (LEU106)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4zpt:L     (ASP1) to   (ALA109)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1tet:L     (LEU3) to   (ILE106)  CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS  |   IMMUNOGLOBULIN 
4lmq:E     (VAL2) to   (SER112)  DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12  |   IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
1ikf:L     (ILE2) to   (ILE106)  A CONFORMATION OF CYCLOSPORIN A IN AQUEOUS ENVIRONMENT REVEALED BY THE X-RAY STRUCTURE OF A CYCLOSPORIN-FAB COMPLEX  |   IMMUNE SYSTEM-IMMUNOSUPPRESSANT COMPLEX, FAB-CYCLOSPORIN COMPLEX, CYCLOSPORIN A, IMMUNOSUPPRESSANT 
3wii:M     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.  |   IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM 
1jfq:L     (ILE2) to   (ILE106)  ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71, "FAB 36-71"  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
5c9k:A     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:B     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:C     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:E     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:F     (PHE2) to   (THR109)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:G     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5c9k:H     (PHE2) to   (VAL110)  CRYSTAL STRUCTURE OF A HIGHLY FIBRILLOGENIC ARG24GLY MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2  |   LAMBDA VI SUBGROUP, BETA-SANDWICH, IMMUNOGLOBULIN, AL AMYLOIDOSIS, IMMUNE SYSTEM 
5eoc:L     (VAL3) to   (ILE110)  CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I  |   COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM 
3cfd:L     (ILE2) to   (ILE106)  PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
3cfd:A     (ILE2) to   (ILE106)  PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
3cfe:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10  |   IMMUNOGLOBULIN, PURPLE-FLUORESCENT ANTIBODY, HAPTEN COMPLEX, IMMUNE SYSTEM 
5gru:H   (GLN137) to   (ILE240)  STRUCTURE OF MONO-SPECIFIC DIABODY  |   DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM 
5hys:L     (GLN3) to   (THR113)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:B     (GLN3) to   (ILE110)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:D     (GLN3) to   (ILE110)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:F     (GLN3) to   (THR113)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM